BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27167109)

  • 1. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
    Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
    Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
    Ghazani AA; Oliver NM; St Pierre JP; Garofalo A; Rainville IR; Hiller E; Treacy DJ; Rojas-Rudilla V; Wood S; Bair E; Parello M; Huang F; Giannakis M; Wilson FH; Stover EH; Corsello SM; Nguyen T; Rana HQ; Church AJ; Lowenstein C; Cibulskis C; Amin-Mansour A; Heng J; Brais L; Santos A; Bauer P; Waldron A; Lo P; Gorman M; Lydon CA; Welch M; McNamara P; Gabriel S; Sholl LM; Lindeman NI; Garber JE; Joffe S; Van Allen EM; Gray SW; Ja Nne PA; Garraway LA; Wagle N
    Genet Med; 2017 Jul; 19(7):787-795. PubMed ID: 28125075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Existing and emerging technologies for tumor genomic profiling.
    MacConaill LE
    J Clin Oncol; 2013 May; 31(15):1815-24. PubMed ID: 23589546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.
    Wang F; Zhang S; Kim TB; Lin YY; Iqbal R; Wang Z; Mohanty V; Sircar K; Karam JA; Wendl MC; Meric-Bernstam F; Weinstein JN; Ding L; Mills GB; Chen K
    Nat Methods; 2019 May; 16(5):401-404. PubMed ID: 30988467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
    Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
    Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in understanding cancer genomes through second-generation sequencing.
    Meyerson M; Gabriel S; Getz G
    Nat Rev Genet; 2010 Oct; 11(10):685-96. PubMed ID: 20847746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.
    Rusch M; Nakitandwe J; Shurtleff S; Newman S; Zhang Z; Edmonson MN; Parker M; Jiao Y; Ma X; Liu Y; Gu J; Walsh MF; Becksfort J; Thrasher A; Li Y; McMurry J; Hedlund E; Patel A; Easton J; Yergeau D; Vadodaria B; Tatevossian RG; Raimondi S; Hedges D; Chen X; Hagiwara K; McGee R; Robinson GW; Klco JM; Gruber TA; Ellison DW; Downing JR; Zhang J
    Nat Commun; 2018 Sep; 9(1):3962. PubMed ID: 30262806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.
    Saldivar JS; Harris J; Ayash E; Hong M; Tandon P; Sinha S; Hebron PM; Houghton EE; Thorne K; Goodman LJ; Li C; Marfatia TR; Anderson J; Morra M; Lyle J; Bartha G; Chen R
    Oncotarget; 2023 Aug; 14():789-806. PubMed ID: 37646774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test.
    Tomlins SA; Hovelson DH; Harms P; Drewery S; Falkner J; Fischer A; Hipp J; Kwiatkowski K; Lazo de la Vega L; Mitchell K; Reeder T; Siddiqui J; Vakil H; Johnson DB; Rhodes DR
    J Mol Diagn; 2021 Nov; 23(11):1515-1533. PubMed ID: 34454112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated next-generation profiling of genomic alterations in human cancers.
    Keefer LA; White JR; Wood DE; Gerding KMR; Valkenburg KC; Riley D; Gault C; Papp E; Vollmer CM; Greer A; Hernandez J; McGregor PM; Zingone A; Ryan BM; Deak K; McCall SJ; Datto MB; Prescott JL; Thompson JF; Cerqueira GC; Jones S; Simmons JK; McElhinny A; Dickey J; Angiuoli SV; Diaz LA; Velculescu VE; Sausen M
    Nat Commun; 2022 May; 13(1):2830. PubMed ID: 35595835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
    Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
    Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.
    Koeppel F; Bobard A; Lefebvre C; Pedrero M; Deloger M; Boursin Y; Richon C; Chen-Min-Tao R; Robert G; Meurice G; Rouleau E; Michiels S; Massard C; Scoazec JY; Solary E; Soria JC; André F; Lacroix L
    Cancer J; 2018; 24(4):153-162. PubMed ID: 30119077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.